A Study of Multiple Ascending Doses MY008211A in Healthy Adults
Phase 1
Completed
- Conditions
- Paroxysmal Nocturnal Hemoglobinuria
- Interventions
- Drug: MY008211A tabletsDrug: MY008211A tablets matched placebo
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT05828472
- Locations
- 🇨🇳
The Third Hospital of Changsha, Changsha, Hunan, China
A Study of Single-dose MY008211A in Healthy Adults
Phase 1
Completed
- Conditions
- Paroxysmal Nocturnal Hemoglobinuria
- Interventions
- Drug: MY008211A tabletsDrug: Placebo
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Target Recruit Count
- 63
- Registration Number
- NCT05642585
- Locations
- 🇨🇳
The Third Hospital of Changsha, Changsha, Hunan, China
© Copyright 2025. All Rights Reserved by MedPath